- Enhance the biopharmaceutical industry in Japan/Asia through the further expansion of currently the US/Europe-focused KBI’s business into Japan/Asia, with the acquisition of cutting-edge U.S. technology and expertise in the development and manufacturing o
- Drive biopharmaceutical drug discovery by establishing a value chain from research, development, and manufacturing, combined with INCJ’s network of Japanese biotechnology companies and small- and medium-sized pharmaceutical companies
Our Portfolio
KBI Biopharma Inc.
| Outline | Biopharmaceutical contract analytical/process development/manufacturing services for large pharmaceutical companies and biotechnology companies |
|---|---|
| Website | |
| Industry | Health/medicine |
| Commercialization stage | Utilization of overseas management resources |
Provided Support
| Authorized Investment | US$50 million (maximum) |
|---|---|
| Investment Structure |